Skip to main content

ARROWHEAD PHARMACEUTICALS INC

For the period ended Jan 28, 2025. Filed Jan 29, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jan 28, 2025 · Filed Jan 29, 2025

ARWR$58.16+1.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Record Date

Only holders of record of our common stock at the close of business on January 17, 2025 (the “Record Date”) are entitled to notice of the Annual Meeting and to vote at the Annual Meeting. On that date, the Company had outstanding 125,073,046 shares of common stock (“Common Stock”).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.